Eosinophlic pneumonia in a patient with anticentromere antibody Hiroaki Satoh, Katsunori Kagohashi, Gen Ohara, Kunihiko Miyazaki, Koichi Kurishima

Why choose cyclosporin A as first-line therapy in COVID-19 pneumonia Olga Sanchez-Pernaute, Fredeswinda I. Romero-Bueno, Albert Selva-O’Callaghan

Experience With the Use of Baricitinib and Tocilizumab Monotherapy or Combined, in Patients With Interstitial Pneumonia Secondary to Coronavirus COVID19: A Real-World Study José Rosas, Francisco Pasquau Liaño, Mónica Llombart Cantó, José María Carrasco Barea, Amparo Raga Beser, José Tomás Algado Rabasa, Francisco Martínez Adsuar, Brian Vila Auli, Isabel Fernández López, Ana María Garijo Sainz, Pere Esquerdo Ramis, Laura Ruiz Pérez, Mª Luisa Navarrete Rebollo, Raquel Hernández Lorido, Laura Gómez Escolar